Astec Lifesciences (NSE:ASTEC) Beta: 1.2404 (As of Jun. 25, 2026)


NSE:ASTEC Astec Lifesciences Ltd NSE:ASTEC
75 GF Score
Price ₹725.45
GF Value ₹976.08
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Astec Lifesciences Beta?

Astec Lifesciences NSE:ASTEC -3.52% 75 Beta is 1.2404 as of Jun. 25, 2026. GuruFocus rates NSE:ASTEC with a GF Score™ of 75/100 and a GF Value™ of ₹976.08 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-25), Astec Lifesciences's Beta is 1.2404.


Astec Lifesciences  (NSE:ASTEC) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Astec Lifesciences Beta Related Terms


Astec Lifesciences Beta Historical Data

* Premium members only.

The historical data trend for Astec Lifesciences's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astec Lifesciences Beta Chart

Astec Lifesciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.32 0.40 0.97 1.05

Astec Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 1.31 1.40 1.14 1.05

NSE:ASTEC vs CTVA, CF: Beta Comparison

For the Agricultural Inputs subindustry, Astec Lifesciences's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Astec Lifesciences Beta vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Beta distribution charts can be found below:

* The bar in red indicates where Astec Lifesciences's Beta falls into.


NSE:ASTEC
75GF Score
Astec Lifesciences Ltd NSE:ASTEC
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astec Lifesciences Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.2404 mean?
Astec Lifesciences (NSE:ASTEC) has a Beta of 1.2404 as of Jun. 25, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Astec Lifesciences and its competitors.
Is Astec Lifesciences' Beta too high?
Astec Lifesciences' current Beta is 1.2404. Overall, Astec Lifesciences has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Beta compare to CTVA and CF?
Astec Lifesciences' Beta of 1.2404 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for an Agriculture company?
A good Beta depends on the Agriculture industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Astec Lifesciences and its competitors. Astec Lifesciences's current Beta is 1.2404. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹976.08, compared to a current price of ₹725.45 — trading 25.7% below its estimated fair value. The current Beta is 1.2404. Astec Lifesciences' overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Beta is 1.2404 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?

Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued. The current stock price of ₹725.45 is trading 25.7% below its estimated GF Value™ of ₹976.08. GuruFocus considers Astec Lifesciences to be Modestly Undervalued.

Key valuation signals for NSE:ASTEC:

  • Beta: 1.2404
  • GF Value™: ₹976.08 vs. price of ₹725.45 (25.7% below fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Astec Lifesciences Business Description

Other Exchanges 533138:India
Address Eastern Express Highway, Godrej One, 3rd Floor, Pirojshanagar, Vikhroli (East), Mumbai, MH, IND, 400 079
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
75GF Score

Get the complete analysis for NSE:ASTEC

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹725.45
Price
₹976.08
GF Value